James McWilliams

A year ago, when the United States decided to go big on vaccines, it bet on nearly every horse, investing in a spectrum of technologies. The safest bets, in a way, repurposed the technology behind existing vaccines, such as protein-based ones for tetanus or hepatitis B. The medium bets were on vaccines made by Johnson & Johnson and AstraZeneca, which use adenovirus vectors, a technology that had been tested before but not deployed on a large scale. The long shots were based on the use of mRNA, the newest and most unproven technology.

The protein-based vaccines have moved too slowly to matter so far. J&J’s and AstraZeneca’s vaccines are effective at preventing COVID-19—but a small number of recipients have developed a rare type of blood clot that appears to be linked to the adenovirus technology and may ultimately limit those shots’ use. Meanwhile, with more than 180 million doses administered in the U.S, the mRNA vaccines have proved astonishingly effective and extremely safe. The unusual blood clots have not appeared with Pfizer’s or Moderna’s mRNA technology. A year later, the risky bet definitely looks like a good one.

Americans will soon begin to fall back into the rhythms of pre-pandemic life—attending sunny summer weddings, squishing into booths at chain restaurants, laughing together at movies on the big screen—and it will feel like a victory over the coronavirus. But the virus might not actually be gone. In pockets of the country, vaccination rates could stay low, creating little islands where the coronavirus survives and thrives—sickening and killing people for months after the pandemic has ebbed elsewhere. In a worst-case scenario, the virus could mutate, becoming a highly transmissible and much more lethal version of itself. Eventually, the new variant could leak from these islands and spread into the broader population, posing a threat to already-vaccinated people.

Last week, the CDC acknowledged what many of us have been saying for almost nine months about cleaning surfaces to prevent transmission by touch of the coronavirus: It’s pure hygiene theater.

“Based on available epidemiological data and studies of environmental transmission factors,” the CDC concluded, “surface transmission is not the main route by which SARS-CoV-2 spreads, and the risk is considered to be low.” In other words: You can put away the bleach, cancel your recurring Amazon subscription for disinfectant wipes, and stop punishing every square inch of classroom floor, restaurant table, and train seat with high-tech antimicrobial blasts. COVID-19 is airborne: It spreads through tiny aerosolized droplets that linger in the air in unventilated spaces. Touching stuff just doesn’t carry much risk, and more people should say so, very loudly.

Washington in the first days of the Biden administration is a place for double takes: A president associated with the politics of austerity is spending money with focused gusto, a crisis isn’t going to waste, and Senator Bernie Sanders is happy.

People like to tell you they saw things coming. But as I talked to many of the campers in Joe Biden’s big tent, particularly those who, like me, were skeptical of Biden, I found that the overwhelming sentiment was surprise. Few of us expected that this president—given his record, a knife’s-edge Congress, and a crisis that makes it hard to look an inch beyond one’s nose—would begin to be talked about as, potentially, transformational.

Biden, after all, was a conservative Democrat who has exuded personal decency more than he has pushed for structural decency. One conservative publication labeled him “the senator from MBNA” for his friendliness to credit-card companies. He conducted the Clarence Thomas–Anita Hill hearings in a way that hurt Hill, for which he later expressed regret. He voted for the Iraq War and eulogized the segregationist Senator Strom Thurmond. He began his 2020 campaign telling wealthy donors that, in his vision, “nobody has to be punished. No one’s standard of living will change, nothing would fundamentally change.”

Dear Therapist,

Our daughter is engaged to a very nice man who is neither American nor of her religion. They are living together and working in his country. She is beautiful and talented, and has a graduate degree. She had a hard time securing work in that country, and now that she has found a job, she is miserable in it. She calls me every few weeks, but beyond the cursory “How are you?” she calls only to complain, whether it’s about her boss, or the work itself not being what she thought it would be, or the language barrier.

She gave up a very successful and lucrative career in the States to go to graduate school abroad, intending to stay there for work and romance. I had advised her against it.

Have you fallen for a famous great ape, the most lovable star of something called the “MonsterVerse”? You’re Kong-pilled. Have you been convinced by a local restaurateur that an imported Italian oil is actually worth the expense? You’re truffle-pilled. Have you inadvertently become entranced by Marxist perspectives on mass media and popular culture? You’re Horkheimer and Adorno–pilled.

All over the internet, people are claiming to be “pilled” by anything you can imagine. Like lots of memes, this one comes from pop culture. In the 1999 movie The Matrix, the protagonist is presented with a choice: Take a red pill or a blue pill. The red pill will wake you up to all the horrors of reality, and the blue pill will let you stay clueless and happy in a simulated dreamworld. But unlike lots of memes, this one didn’t start as a neutral joke about a famous movie. About eight years ago, boys who were spending too much time on the internet—usually on 4chan or Reddit—began to use taking the red pill as code for “choosing to realize that feminism is destroying society and my life.” The phrase was adopted by other far-right political subcultures and slowly came to mean that a person had been radicalized in some way.

This article is part of a new series called “Who Owns America’s Wilderness?”

It’s late afternoon, late pandemic, and I’m watching a new nature documentary in bed, after taking the daintiest of hits from a weed pen. The show is called A Perfect Planet, and it is narrated by Sir David Attenborough.

I am looking at the red eye of a flamingo, a molten lake surrounding a tiny black pupil. Now I am looking at drone footage of a massive colony of flamingos, the classic sweeping overhead shot, what my brother calls “POV God.” Behind the images, a string orchestra sets the mood, giving the coral-pink birds an otherworldly theme in E minor.

Nature documentaries have never been more popular, in part because they offer easy escapism during a rough time, and in part because marijuana has been legalized in much of the United States. The combination is hard to resist, as my experience with A Perfect Planet proves. The stoned attention span perfectly matches the length of each vignette, in which Attenborough’s soothing, avuncular voice guides you through a simple story about animal life. In between, you are treated to epic, empty landscapes and intense close-ups of the rich colors and textures of the nonhuman world, which pop off like fireworks in your wide-open mind. The effect is awe-inspiring but also surprisingly chill. And there are no troublesome humans on-screen to kill the vibe.

This article was published online on April 14, 2021.

Embarrassment makes for rich literature, but few fictions I can think of capture humiliation with the brute efficiency of “Traumarama.” The series, which ran for a time in Seventeen magazine, offered true stories written by, and for, teenagers—three or so lines, poetic in their brevity, about unruly bodies and unforgiving worlds. Crushes were a common topic. So were pimples and periods. White pants, in the world of “Traumarama,” were Chekhov’s gun.

The series was silly. As a kid, I loved it anyway. It offered commiseration and catharsis. Its mini-melodramas were tales of embarrassment that, in the end, defied embarrassment: How mortifying should any of this be, if so many others were living through it, too?

By the time you read this, at least a quarter of Americans will have received at least one dose of a COVID-19 vaccine. It’s a stunning turnaround for a country where a bungled early response, inadequate financial support to keep people home, and a mishmash of mask requirements have led to more than 30 million infections and more than 554,000 deaths.

Just north of the border, Canadians—usually so smug about our universal health care—are looking on with jealousy. “Here, vaccine envy has turned into a national psychosis, another reason to beat ourselves up for some fatal national flaw,” wrote Alan Freeman, a journalist turned public servant and academic on iPolitics, a Canadian news website. In The Globe and Mail, the columnist Ian Brown retells an encounter with a vaccinated person: “I immediately wanted revenge. Nothing serious: steal his car, maybe, or his wallet.”

I am one of the nearly 7 million Americans with the Johnson & Johnson vaccine percolating through my tissue at this very moment. It feels good. The sensation of rising immunity to COVID-19 would almost certainly still feel good if I were a woman between the ages of 18 and 48, like all six of the vaccine recipients who later suffered from blood clots. The clots, which might or might not be related to the vaccine, can kill you; one of the six patients died. If you treat the clots the wrong way, the treatment can kill, too—which is why the CDC and FDA paused J&J vaccination yesterday morning, and left the vaccine in my body a limited-edition commodity, like a final gulp of Coke Classic.

Let’s say the connection to the clots is confirmed and the numbers hold. If COVID-19 shots are seasonal, like the flu shot, and you have to get one every year, then your COVID-19 shot will on average kill you if you live to be 7 million years old, which by the way is a serious comorbidity in itself. Government health authorities have to think about low-probability events, and they sometimes withhold drugs from mass distribution because of rare adverse effects. But the J&J vaccine should be redeployed to the front lines of the COVID-19 war as soon as possible, and it should not have been removed from service in the first place.